Furthermore, in vivo experiments showed that INH14 decreased TNFα formed after lipopeptide‐induced inflammation, and treatment of ovarian cancer cells with INH14 led to a reduction of NF‐kB constitutive activity and a reduction in the wound‐closing ability of these cells. Here, NFKB1 is linked to ovarian carcinoma.